AzTrials
AzTrials

Healthy VolunteersPhase 1/2NCT06258941

Classroom Break, Cognition, and Fitness in Elementary School Children

A Phase 1/2 study testing MF-HIIT, HIIT-only and MF-only in people with Healthy Volunteers, run by Purdue University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to learn about the effect of a 12-week school-based intervention combining mindfulness with high-intensity interval training (MF-HIIT), MF-only intervention, and HIIT-only intervention in relative to sedentary activities on executive function (EF) in 8-12 years old… Read more about this study

Who is it for?
Ages 8 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
MF-HIIT, HIIT-only and MF-only
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
352 participants
Where
1 siteUnited States
Study dates
14 Feb 2025to 31 May 2027
Phase
Phase 1/2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age between 8-12 years old
  • Intelligence Quotient ≥ 70
  • Capable of performing exercise based on pre-participation health screening
  • No formal diagnosis of neurological diseases (e.g., epilepsy)

Who cannot join

  • Age outside of the range of 8-12 years old
  • Intelligence Quotient < 70
  • No capable of performing exercise based on pre-participation health screening
  • Has formal diagnosis of neurological diseases (e.g., epilepsy)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Shih-Chun (Alvin) Kao, PhD contact

765-496-2213

kao28@purdue.edu

United States1 site, 1 recruiting
  • Pioneer Elementary School

    Royal Center, Indiana, 46978

    Pat Principal Quillen, 574-643-2255, quillenp@pioneer.k12.in.us

    Recruiting

Other trials in United States

About this study

Official title: Supporting High-intensity Interval Training With Mindfulness for Enhancing Childhood Executive Function

The goal of this randomized controlled trial is to learn about the effect of a 12-week school-based intervention combining mindfulness with high-intensity interval training (MF-HIIT), MF-only intervention, and HIIT-only intervention in relative to sedentary activities on executive function (EF) in 8-12 years old children. The main question it aims to answer is whether a 12-week school-based MF-HIIT intervention has larger beneficial effect on EF performance than that following a 12-week school-based MF-only and HIIT-only in relative to the sedentary activities.

Multiple cohorts of participants will be recruited to participate this one-semester study, including the pretest, intervention, and posttest phases.

Read more

During the pretest phase, participants an their parents will complete the following

  1. Kaufman Brief Intelligence Test (KBIT) to assess intelligence quotient
  2. Fitnessgram test to assess aerobic capacity, muscle endurance, flexibility, and body mass index
  3. Child and Adolescent Mindfulness Measure (CAMM) questionnaire to assess dispositional mindfulness
  4. Computerized tasks to assess EF
  5. Parent-reported demographic and health information

Following the pretest phase, participants will receive the 12-week classroom-based intervention, with the classroom as the intervention unit.

Following the intervention and during the posttest phase, participants will complete the fitness, measures, EF measures, and dispositional mindfulness measure again.

Researcher will compare the EFn outcome measures following the MF-HIIT, MF-only, and HIIT-only interventions with the sedentary activity intervention to see if MF and HIIT has beneficial effects on children's EF.

Further, researcher will compare the EF measures following the MF-HIIT compared with MF-only and HIIT-only interventions to see if combining MF with HIIT has greater beneficial effects on children's EF than MF and HIIT alone.

Being tested
MF-HIIT, HIIT-only, MF-only, Sedentary activity
Keywords
Executive function, Mindfulness, Interval exercise, Children, Fitness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MF-HIITBehavioural

    Two 10-min MF-HIIT sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.

  • HIIT-onlyBehavioural

    Two 10-min HIIT-only sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.

  • MF-onlyBehavioural

    Two 10-min MF-only sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.

  • Sedentary activityBehavioural

    Two 10-min sedentary sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.

Study groups in NCT06258941
Study groupRoleWhat they receive
12-Week Mindful High-Intensity Interval Training (MF-HIIT)ExperimentalNot described
Receives: Behavioral: MF-HIIT
12-Week High-Intensity Interval Training (HIIT-only)Active comparatorNot described
Receives: Behavioral: HIIT-only
12-Week Mindfulness (MF-only)Active comparatorNot described
Receives: Behavioral: MF-only
12-Week Sedentary ActivitiesPlacebo comparatorNot described
Receives: Behavioral: Sedentary activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inhibition speed

    Inhibition speed will be assessed by the response time (ms) during a child-friendly flanker task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  2. Inhibition accuracy

    Inhibition accuracy will be assessed by the response accuracy (percent) during a child-friendly flanker task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  3. Updating speed

    Updating speed will be assessed by the response time (ms) during a child-friendly n-back task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  4. Updating accuracy

    Updating accuracy will be assessed by the response accuracy (percent) during a child-friendly n-back task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  5. Shifting speed

    Shifting speed will be assessed by the response time (ms) during a child-friendly switching task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  6. Shifting accuracy

    Shifting accuracy will be assessed by the response accuracy (percent) during a child-friendly switching task.

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

Secondary outcomes (6)
  1. Aerobic capacity

    Aerobic capacity will be assessed by the Progressive Aerobic Cardiovascular Endurance Run (PACER) test

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  2. Upper body muscle endurance

    Upper body muscle endurance will be assessed by the push-ups test

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  3. Core body muscle endurance

    Core body muscle endurance will be assessed by the curl-ups test

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  4. Flexibility

    Flexibility will be assessed by the back-saver sit and reach test

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  5. Body composition

    body composition will be assessed by the body mass index computed as weight (kg) / (height [m] * height [m])

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

  6. Dispositional mindfulness

    Dispositional mindfulness will be assessed by the Child and Adolescent Mindfulness Measure questionnaire (CAMM). The questionnaire has 10 items and requires the respondents to rating each item using a 5-point likert scale from 0 (Never True) to 4 (Always True). Higher summed scores indicate higher levels of mindfulness

    Measured: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2024
  2. Study start14 Feb 2025
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
352 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06258941
Sponsor's protocol ID
IRB-2024-1588
Other IDs
1R21HD110656-01A1
Status last verified
Jun 2026
First submitted
6 Feb 2024
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing MF-HIIT, HIIT-only and MF-only in people with Healthy Volunteers, run by Purdue University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shih-Chun (Alvin) Kao, PhD (765-496-2213, kao28@purdue.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inhibition speed (time frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in